Loading...
Tissue Repair Ltd
TRP.AX•ASX
Healthcare
Biotechnology
A$0.26
A$0.02(6.25%)
Tissue Repair Ltd (TRP.AX) Financial Performance & Income Statement Overview
Review Tissue Repair Ltd’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
4849.28%
↑ 4849.28%
Operating Income Growth
15.06%
↑ 15.06%
Net Income Growth
0.87%
↑ 0.87%
Operating Cash Flow Growth
-16.35%
↓ 16.35%
Operating Margin
-232.28%
↓ 232.28%
Gross Margin
99.78%
↑ 99.78%
Net Profit Margin
-186.12%
↓ 186.12%
ROE
-26.42%
↓ 26.42%
ROIC
-35.54%
↓ 35.54%
Tissue Repair Ltd (TRP.AX) Income Statement & Financial Overview
Review Tissue Repair Ltd's (TRP.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $1.73M | $58586.00 | $3076.00 | $485828.00 |
| Cost of Revenue | $5218.00 | $916952.00 | $1530.00 | $0.00 |
| Gross Profit | $1.73M | -$858366.00 | $1546.00 | $485828.00 |
| Gross Profit Ratio | $1.00 | -$14.65 | $0.50 | $1.00 |
| R&D Expenses | $2.25M | $987101.00 | $840682.00 | $420341.00 |
| SG&A Expenses | $1.83M | $688139.00 | $1.52M | $758596.00 |
| Operating Expenses | $4.08M | $1.68M | $2.36M | $1.15M |
| Total Costs & Expenses | $4.09M | $2.59M | $2.36M | $1.15M |
| Interest Income | $695052.00 | $395850.00 | $315979.00 | $157990.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1830.00 | $814.00 | $1530.00 | $765.00 |
| EBITDA | -$2.34M | -$2.26M | -$1.99M | -$693110.00 |
| EBITDA Ratio | -$1.35 | -$43.23 | -$765.54 | -$1.43 |
| Operating Income | -$2.35M | -$2.53M | -$2.36M | -$693875.00 |
| Operating Income Ratio | -$1.36 | -$43.25 | -$766.04 | -$1.43 |
| Other Income/Expenses (Net) | -$1.17M | $276597.00 | $367529.00 | $182998.00 |
| Income Before Tax | -$3.52M | -$2.26M | -$1.99M | -$510111.00 |
| Income Before Tax Ratio | -$2.03 | -$38.52 | -$646.55 | -$1.05 |
| Income Tax Expense | -$1.64M | -$4.00 | -$968579.00 | $0.00 |
| Net Income | -$1.88M | -$2.26M | -$1.02M | -$510111.00 |
| Net Income Ratio | -$1.09 | -$38.52 | -$331.67 | -$1.05 |
| EPS | -$0.03 | -$0.04 | -$0.02 | -$0.008 |
| Diluted EPS | -$0.03 | -$0.04 | -$0.02 | -$0.008 |
| Weighted Avg Shares Outstanding | $60.46M | $60.46M | $60.46M | $60.47M |
| Weighted Avg Shares Outstanding (Diluted) | $60.46M | $60.46M | $60.46M | $60.46M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan